期刊文献+

内皮素受体阻滞剂对皮瓣坏死的影响

The effects of ET receptor antagonists on skin flap necrosis
下载PDF
导出
摘要 目的 研究内皮素受体A选择性阻滞剂BQ - 12 3对任意皮瓣的存活是否有影响。方法 在SD大鼠背部肉膜下形成任意皮瓣 ,分成用药组和对照组。测皮瓣存活率 ,取材进行HE染色光镜检查 ,使用激光多谱勒血流仪测量皮瓣血运情况 ,测SOD、GSH -PX的活性及MDA含量。结果 术后第 10天 ,用药组皮瓣的存活率显著高于对照组 (P <0 .0 1)。HE染色光镜检查见用药组的组织损害较对照组小。激光多谱勒测量发现用药组较对照组LDF值下降少 ,恢复快。用药组较对照组SOD及GSH -PX的活性下降少 ,恢复快 ,MDA值则上升少 ,恢复快。结论 内皮素受体阻滞剂BQ - 12 Objective To investigate whether ET receptor specific antagonist BQ-123 influences necrosis in random pattern skin flaps of rats. Methods 120 rats were designed randomly into 12 groups. We took two groups each time. BQ-123 were injected in group, the control group received an injection of drug-free normal saline. We measured surviving portion of the flap and observed the tissue by light microscope. Using Doppler ultrasound we measured the blood flow, MDA, SOD, GSH-PX were also measured. Results The flap survival area of BQ-123 injection group was significantly greater (P<0.01) than that of the control. Under light microscope, we found the tissue in BQ-123 group swelled less than the control. In every point (except 10 th day postoperatively and preoperation) the blood flow detected in BQ-123 group was significantly higher than that of the control group (P<0.01). In every point (except preoperation) SOD and GSH-PX in BQ-123 groups were significantly higher than those of the control groups (P<0.01). MDA were significantly lower than those of the control groups at 1 std, 4 thd, 7 thd postoperatively. Conclusion BQ-123, a kind of ET receptor specific antagonist, can significantly promote survival of skin flap.
出处 《实用美容整形外科杂志》 2003年第4期181-184,共4页 Journal of Practical Aesthetic and Plastic Surgery
关键词 内皮素受体阻滞剂 皮瓣坏死 内皮素受体A SD大鼠 激光多谱勒血流仪 存活率 Endothelin Endothelin receptor antagonist Endothelin receptor Flap
  • 相关文献

参考文献8

  • 1Nichter LS, Sobieski MW, Edgerton MT. Efficacy of topical nitroglycerin for random - pattern skin - flap salvage[J ]. Plast Reconstr Surg, 1985, 75(6): 847.
  • 2Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells [ J ].Nature, 1988, 332(6163): 411.
  • 3Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes[ J ]. Proe Natl Acad Sci USA, 1989, 86(8): 2863.
  • 4Tane N, Inoue H, Aihara M, et al. The effects of endothelin - 1 on flap necrosis[J]. Ann Plast Surg, 1995, 35(4): 389.
  • 5Matsuzaki K. Effect of skin flap ischemia on plasma endothelin - 1 levels [J]. Ann Plast Surg, 1993, 31(6): 499.
  • 6Tuominen HP, Svartling NE, Tikkanen IT, et al. The effect of felodipineon endothelin - 1 levels, peripheral vasoconstrietion and flap survival during microvascular breast reconstruction [3 ]. Br J Plast Surg, 1997, 50(8): 624.
  • 7Donckier J, Stoleru L, Hayashida W, et al. Role of endogenous endothelin- 1 in experimental renal hypertension in dogs[J]. Circulation, 1995, 92(1): 106.
  • 8Anggard E, Galton S, Rae G, et al. The fate of radioiodinated endothelin - 1 and endothelin -3 in the rat[J]. J Cardiovasc Pharmacol, 1989, 13(suppl 5): 46.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部